Brigitte Anliker is a non-clinical assessor for Advanced Therapy Medicinal Products at the Paul-Ehrlich-Institut in Germany, and a member of the Non-clinical Working Party at the European Medicines Agency.

She completed her Ph.D. at the Max Planck Institute for Brain Research and was a postdoctoral researcher at the Scripps Research Institute and Heinrich-Heine University. Since joining the Paul-Ehrlich-Institut in 2008, she has mainly evaluated clinical trials and marketing authorization applications of Gene Therapy Medicinal Products.